We are excited to share that our Head of Biostatistics, Prof. Krassimir Kalinov, has recently contributed as an author to several new publications, including:
• COVID-19 Infection in Chronic Kidney Disease Patients: Risk Factors for Death and Acute Kidney Injury – https://pubmed.ncbi.nlm.nih.gov/36294815/
• Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease – https://pubmed.ncbi.nlm.nih.gov/36983566/
• Renin-angiotensin-aldosterone system blockers in COVID-19 patients with or without chronic kidney disease – https://pubmed.ncbi.nlm.nih.gov/36482641/
• Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population – https://pubmed.ncbi.nlm.nih.gov/36252915/
We are confident that Prof. Kalinov’s contributions will further enhance the scientific community’s understanding of different diseases and the application of Biostatistics in real-world settings.
As an organization committed to science, Comac Medical continues to support scientific activities through our daily activities and not only.
Constant Contribution to Science
April 4, 2023
Share:
News
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...